Ironwood Pharmaceuticals (IRWD) Capital Expenditures (2010 - 2025)

Ironwood Pharmaceuticals (IRWD) has 16 years of Capital Expenditures data on file, last reported at -$1000.0 in Q4 2025.

• For the quarter ending Q4 2025, Capital Expenditures changed N/A year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2025 stood at $34000.0 (down 76.06% YoY), and the FY2025 full-year result was $34000.0, down 76.06% from the prior year.
• Capital Expenditures slipped to -$1000.0 in Q4 2025, from $2000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $211000.0 in Q4 2023 to a low of -$27000.0 in Q4 2022.
• A 5-year average of $47533.3 and a median of $31000.0 in 2025 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures sank 121.09% in 2022 and surged 881.48% in 2023, its largest moves.
• Tracing IRWD's Capital Expenditures over 5 years: stood at $128000.0 in 2021, then slumped by 121.09% to -$27000.0 in 2022, then surged by 881.48% to $211000.0 in 2023, then sank by 92.42% to $16000.0 in 2024, then tumbled by 106.25% to -$1000.0 in 2025.
• Business Quant data shows IRWD's Capital Expenditures at -$1000.0 in Q4 2025, $2000.0 in Q3 2025, and $2000.0 in Q2 2025.